Life Sciences

FDA releases updated draft guidance for ANA test systems

Device Regulation Alert: Safety, Compliance and Reimbursement News, February 9, 2009

New developments for in vitro diagnostic devices prompted the FDA to release a revised guidance document, “Recommendations for Anti-Nuclear Antibody (ANA) Test System Premarket (510(k)) Submissions.”

Post a Comment

Name:

 

E-mail:

 

Please enter your comment below:

   

Please enter the text below:

   
   

Most Popular